In the early 1980’s, physicians in San Francisco and New York were puzzled by a growing number of aggressive cases of a rare malignancy known as Kaposi’s sarcoma, as well as a rare lung infection, Pneumocystis carinii (now "jirovecii") pneumonia. These illnesses were discovered initially in homosexual men, but were later seen in a growing number of patients suffering from hemophilia.
Seemingly random discussions on various transfusion medicine topics by Joe Chaffin, MD
Showing posts with label FDA. Show all posts
Showing posts with label FDA. Show all posts
Wednesday, February 9, 2011
Friday, January 7, 2011
Volunteer?
When is a "volunteer" really a volunteer? For blood donor centers, this is a hugely important question to ask, since keeping an all-volunteer blood supply has been considered a mainstay of transfusion medicine for at least the last 25 years. I attended an interesting lecture today given by an incredibly knowledgable person (Gina Ramirez, manager of regulatory affairs) at the blood center where I work, and thought I would share some information from her lecture and my thoughts with you here.
Subscribe to:
Posts (Atom)